Risk factor
Negligible price volatility
Profitability factor
Greatly overvalued vs peers
About
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBIT
Target Price
The average target price of VTR is 77 and suggests 1% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to decreas
Buy
Sell